Follow the 爱尔眼科 share price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 爱尔眼科 has recorded 49 insider filings. Market capitalisation: €84.4bn. The latest transaction was reported on 15 July 2022 (Purchase). Among the most active insiders: 吴士君. All data is free.
49
Insider Decl.
n/a
Thresholds
€10m
49 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 爱尔眼科 Strong Buy (bullish), based on 14 analysts. Average price target: CN¥13.71.
33Σ signal
Buys €10mn/a Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,991 of 29,064 companies
62.7
score / 100
Value
54
Quality
72
FCF yld4.6%
Earn yld3.8%
EV/EBITDA14.2x
ROE15%
Gross mgn47%
Net mgn14%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
